Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
Radioiodine therapy of metastatic differentiated thyroid cancer is a highly effective method of treatment which makes it possible to achieve the complete cure of the majority of patients, however in some cases radioiodine refractory type develops, it leads to significant deterioration in overall and...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2018-04-01
|
| Series: | Opuholi Golovy i Šei |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/320 |
| id |
doaj-f6aebb3910924872bdd68bd69a55124e |
|---|---|
| record_format |
Article |
| spelling |
doaj-f6aebb3910924872bdd68bd69a55124e2021-07-29T08:14:12ZrusABV-pressOpuholi Golovy i Šei2222-14682411-46342018-04-0181242710.17650/2222-1468-2018-8-1-24-27286Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear MedicineE. B. Vasil’eva0A. V. Vazhenin1T. M. Geliashvili2N. V. Fadeeva3A. V. Garev4A. O. Guz’5Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine.Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine; South Ural State Medical University, Ministry of Health of Russia.Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine.Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine.Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine.Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine.Radioiodine therapy of metastatic differentiated thyroid cancer is a highly effective method of treatment which makes it possible to achieve the complete cure of the majority of patients, however in some cases radioiodine refractory type develops, it leads to significant deterioration in overall and relapse-free survival. The article presents own experience of the therapy of radioiodine refractory thyroid cancer by the nexavar (sorafenib).https://ogsh.abvpress.ru/jour/article/view/320differentiated thyroid cancerradioiodine therapysorafenib |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
E. B. Vasil’eva A. V. Vazhenin T. M. Geliashvili N. V. Fadeeva A. V. Garev A. O. Guz’ |
| spellingShingle |
E. B. Vasil’eva A. V. Vazhenin T. M. Geliashvili N. V. Fadeeva A. V. Garev A. O. Guz’ Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine Opuholi Golovy i Šei differentiated thyroid cancer radioiodine therapy sorafenib |
| author_facet |
E. B. Vasil’eva A. V. Vazhenin T. M. Geliashvili N. V. Fadeeva A. V. Garev A. O. Guz’ |
| author_sort |
E. B. Vasil’eva |
| title |
Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine |
| title_short |
Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine |
| title_full |
Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine |
| title_fullStr |
Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine |
| title_full_unstemmed |
Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine |
| title_sort |
experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the chelyabinsk regional clinical center of oncology and nuclear medicine |
| publisher |
ABV-press |
| series |
Opuholi Golovy i Šei |
| issn |
2222-1468 2411-4634 |
| publishDate |
2018-04-01 |
| description |
Radioiodine therapy of metastatic differentiated thyroid cancer is a highly effective method of treatment which makes it possible to achieve the complete cure of the majority of patients, however in some cases radioiodine refractory type develops, it leads to significant deterioration in overall and relapse-free survival. The article presents own experience of the therapy of radioiodine refractory thyroid cancer by the nexavar (sorafenib). |
| topic |
differentiated thyroid cancer radioiodine therapy sorafenib |
| url |
https://ogsh.abvpress.ru/jour/article/view/320 |
| work_keys_str_mv |
AT ebvasileva experienceintheuseoftargetedtherapyinpatientswithradioresistantformsofthyroidcancerinthechelyabinskregionalclinicalcenterofoncologyandnuclearmedicine AT avvazhenin experienceintheuseoftargetedtherapyinpatientswithradioresistantformsofthyroidcancerinthechelyabinskregionalclinicalcenterofoncologyandnuclearmedicine AT tmgeliashvili experienceintheuseoftargetedtherapyinpatientswithradioresistantformsofthyroidcancerinthechelyabinskregionalclinicalcenterofoncologyandnuclearmedicine AT nvfadeeva experienceintheuseoftargetedtherapyinpatientswithradioresistantformsofthyroidcancerinthechelyabinskregionalclinicalcenterofoncologyandnuclearmedicine AT avgarev experienceintheuseoftargetedtherapyinpatientswithradioresistantformsofthyroidcancerinthechelyabinskregionalclinicalcenterofoncologyandnuclearmedicine AT aoguz experienceintheuseoftargetedtherapyinpatientswithradioresistantformsofthyroidcancerinthechelyabinskregionalclinicalcenterofoncologyandnuclearmedicine |
| _version_ |
1721256747867308032 |